Children with cardiomyopathy: complications after noncardiac procedures with general anesthesia

Alaina K Kipps1, Chandra Ramamoorthy, David N Rosenthal

  • 1Pediatric Cardiology, Children's Hospital Boston, Boston, MA, USA.

Insights

Children with cardiomyopathy undergoing general anesthesia (GA) face significant risks, particularly those with severe ventricular dysfunction. Early intensive care support is recommended for these high-risk pediatric patients to improve outcomes.

Area of Science:

  • Pediatric Cardiology
  • Anesthesiology
  • Critical Care Medicine

Background:

  • Children with cardiomyopathy (CM) frequently require procedures under general anesthesia (GA).
  • Limited data exists on anesthesia-related adverse events and postprocedural outcomes in this vulnerable population.
  • Understanding these risks is crucial for optimizing perioperative care.

Purpose of the Study:

  • To investigate anesthesia-related adverse events and postprocedural outcomes in children with cardiomyopathy undergoing non-cardiac procedures.
  • To identify risk factors associated with complications in this cohort.

Main Methods:

  • Retrospective review of pediatric patients with CM undergoing procedures under GA from 2002-2005.
  • Categorization of systemic ventricular dysfunction based on preprocedure fractional shortening (FS).
  • Analysis of procedure types, complications, and resource utilization.

Main Results:

  • Sixty-two percent of patients had severe ventricular dysfunction; 38% had mild/moderate dysfunction.
  • Complications were significantly more frequent in patients with severe dysfunction (83% of complications).
  • Hypotension requiring inotropic support was the most common complication; severe dysfunction was linked to longer hospital stays and intensive care unit (ICU) needs.

Conclusions:

  • While 30-day mortality was low, complications are frequent in children with CM undergoing GA, especially those with severe ventricular dysfunction.
  • Early consideration of perioperative intensive care support is recommended for patients with severe ventricular dysfunction.
  • Optimized cardiovascular therapy and monitoring are essential for this high-risk group.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...